These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7910754)

  • 1. Effects of medication history on midlatency auditory evoked responses in schizophrenia.
    Erwin RJ; Shtasel D; Gur RE
    Schizophr Res; 1994 Feb; 11(3):251-8. PubMed ID: 7910754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midlatency auditory evoked responses in schizophrenia.
    Erwin RJ; Mawhinney-Hee M; Gur RC; Gur RE
    Biol Psychiatry; 1991 Sep; 30(5):430-42. PubMed ID: 1932393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auditory event-related potentials and electrodermal activity in medicated and unmedicated schizophrenics.
    Roth WT; Goodale J; Pfefferbaum A
    Biol Psychiatry; 1991 Mar; 29(6):585-99. PubMed ID: 1675890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
    Stefánsson SB; Jónsdóttir TJ
    Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The P50 component of the auditory evoked potential and subtypes of schizophrenia.
    Boutros N; Zouridakis G; Rustin T; Peabody C; Warner D
    Psychiatry Res; 1993 Jun; 47(3):243-54. PubMed ID: 8372162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed peak latency of the mismatch negativity in schizophrenics and alcoholics.
    Kathmann N; Wagner M; Rendtorff N; Engel RR
    Biol Psychiatry; 1995 May; 37(10):754-7. PubMed ID: 7640331
    [No Abstract]   [Full Text] [Related]  

  • 8. Event-related potential abnormalities correlate with structural brain alterations and clinical features in patients with chronic schizophrenia.
    Egan MF; Duncan CC; Suddath RL; Kirch DG; Mirsky AF; Wyatt RJ
    Schizophr Res; 1994 Feb; 11(3):259-71. PubMed ID: 7910755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N2 and P3 components of event-related potential in first-episode schizophrenic patients: scalp topography, medication, and latency effects.
    Demiralp T; Uçok A; Devrim M; Isoglu-Alkaç U; Tecer A; Polich J
    Psychiatry Res; 2002 Aug; 111(2-3):167-79. PubMed ID: 12374634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients.
    Freedman R; Adler LE; Waldo MC; Pachtman E; Franks RD
    Biol Psychiatry; 1983 May; 18(5):537-51. PubMed ID: 6134559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The P 300 potential in schizophrenia].
    Laurent A; Garcia-Larrea L; Dalery J; Terra JL; D'Amato T; Marie-Cardine M; Mauguière F
    Encephale; 1993; 19(3):221-7. PubMed ID: 8275907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.
    Hong X; Chan RC; Zhuang X; Jiang T; Wan X; Wang J; Xiao B; Zhou H; Jiang L; Weng B
    Schizophr Res; 2009 Mar; 108(1-3):151-7. PubMed ID: 19106034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of maximum variability within event related potentials in schizophrenia.
    Anderson J; Rennie C; Gordon E; Howson A; Meares R
    Psychiatry Res; 1991 Oct; 39(1):33-44. PubMed ID: 1685249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERPs in schizophrenia: effects of antipsychotic medication.
    Ford JM; White PM; Csernansky JG; Faustman WO; Roth WT; Pfefferbaum A
    Biol Psychiatry; 1994 Aug; 36(3):153-70. PubMed ID: 7948453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.
    Adler LE; Olincy A; Cawthra EM; McRae KA; Harris JG; Nagamoto HT; Waldo MC; Hall MH; Bowles A; Woodward L; Ross RG; Freedman R
    Am J Psychiatry; 2004 Oct; 161(10):1822-8. PubMed ID: 15465979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latency increase of auditory-evoked potential component N1 predicts poor neuroleptic response in schizophrenic patients.
    Adler G; Markert U; Gattaz WF
    Pharmacopsychiatry; 1994 Mar; 27(2):68-9. PubMed ID: 7913236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain potential evidence for an auditory sensory memory deficit in schizophrenia.
    Catts SV; Shelley AM; Ward PB; Liebert B; McConaghy N; Andrews S; Michie PT
    Am J Psychiatry; 1995 Feb; 152(2):213-9. PubMed ID: 7840354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia, psychoticism, neuroleptics, and auditory evoked potentials.
    Schlör KH; Moises HW; Haas S; Rieger H
    Pharmacopsychiatry; 1985 Sep; 18(5):293-6. PubMed ID: 4048264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auditory processing in schizophrenia during the middle latency period (10-50 ms): high-density electrical mapping and source analysis reveal subcortical antecedents to early cortical deficits.
    Leavitt VM; Molholm S; Ritter W; Shpaner M; Foxe JJ
    J Psychiatry Neurosci; 2007 Sep; 32(5):339-53. PubMed ID: 17823650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal auditory sensory gating-out in first-episode and never-medicated paranoid schizophrenia patients: an fMRI study.
    Ji B; Mei W; Zhang JX; Jing J; Wu Q; Zhuo Y; Xiao Z
    Exp Brain Res; 2013 Aug; 229(2):139-47. PubMed ID: 23820976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.